Consistent with our hypothesis, MALAT1 promotes the activation of β-catenin and NF-κB pathways by suppressing VHL through a non-canonical function of EZH2 in HNSCC. The gene discussed is NFKB1; the disease is head and neck squamous cell carcinoma.